GYNECOLOGICAL CANCERS. GENETIC AND EPIGENETIC TARGETS AND DRUG DEVELOPMENT

1. Epigenetic Mechanisms in Gynecological Cancer
2. Pharmacoepigenomics and Pharmacovigilance in Gynecological Cancers
3. Advances in Cervical Cancer and Ongoing Clinical Trials
4. Advances in Ovarian Cancer and Ongoing Clinical Trials
5. Novel Methods for Prevention and Early Diagnosis of Ovarian and Endometrial Cancers
6. Developmental Therapeutics for Gynecologic Cancers: An Overview
7. Preservation of Fertility in Gynecological Malignancies
8. Racial/Ethnic Disparities in Gynecological Cancer Screening, Treatment, and Survival

Facilitating the collaboration between the basic, translational, and clinical sciences, this book provides an overview of the genetic and epigenetic mechanisms underlying the formation and progression of gynecological cancers. Gynecological Cancers: Genetic and Epigenetic Targets and Drug Development gathers all of the molecular and cellular aspects of gynecological cancer together within one volume, providing detailed and up-to-date information on the etiology, diagnosis, and treatment of gynecological cancers.
Gynecological Cancers: Genetic and Epigenetic Targets and Drug Development also discusses the racial and ethnic disparities in the treatment of gynecological cancers through cost effective modalities like single visit screening and diagnosis, well women clinics, and mobile clinics. Written and edited by leaders in the field, this volume within the Current Clinical Oncology series is an indispensable resource for today’s practicing oncologist.

Features
• Provides detailed and up-to-date information on the etiology, diagnosis, and treatment of gynecological cancers
• Discusses the diagnosis and treatment of gynecological cancers, including ovarian cancer, uterine cancer, cervical cancer, vaginal cancer, and vulvar cancer
• Provides an overview of the genetic and epigenetic mechanisms underlying the formation and progression of gynecological cancers Discusses cutting-edge bio-molecular approaches to cancer therapy
• Offers an up-to-date molecular and therapeutic link, facilitating the collaboration between the basic, translational, and clinical services
• Discusses the racial/ethnic disparities in screening, treatment, and survival
• Written for research and clinical oncologists, translational cancer scientists, medical and biomedical students

Authors
• Antonio Giordano, MD, PhDProfessorTemple UniversitySbarro Institute for Cancer Research and Molecular Medicine and Center of BiotechnologyDepartment of BiologyPhiladelphia, PA, USA
• Marcella Macaluso, PhDAssociate ProfessorTemple UniversitySbarro Institute for Cancer Research and Molecular Medicine and Center of BiotechnologyDepartment of BiologyPhiladelphia, PA, USA